Stocks in play: MustGrow Biologics Corp.

Today announced that the board of directors of the Company authorized and approved the grant of a total of612,757 deferred share units ("DSUs") and177,035 restricted share units to certain directors, officers, and consultants of the Company, effective August 31, 2023. This grant of DSUs and RSUs is made pursuant to the Company's Omnibus Equity Incentive Plan. MustGrow Biologics Corp. shares V.MGRO are trading unchanged at $1.54.

Read:

• Supply Shortage Could Drive Up Uranium Prices

• Novel Mechanisms Leading the Charge in Fight Against Cancer, Opening Door to New Drugs & Therapies

• Significant Oncology Results Set to be Delivered as Oral Presentations at ASCO 2023

• Promising New Cancer Treatment Data to Be Presented at 2023 ASCO Annual Meeting

• Global Lithium Supply Under Pressure as South American Nations Discuss "Lithium OPEC"